Financial Data and Key Metrics Changes - For the full year ended December 31, 2020, the company reported total GAAP revenue of $391 million, an increase of $52.4 million or 15.5% over the prior year [30] - GAAP diluted earnings per share were $0.52, while non-GAAP adjusted earnings per diluted share were $0.77, representing a 26.2% increase over 2019 adjusted earnings per share of $0.61 [30][31] - The company maintained a net debt-to-adjusted EBITDA ratio of 1.02 times, excluding $28 million of Medicare advance payments received [31] Business Line Data and Key Metrics Changes - The home health and hospice segment achieved approximately 51% adjusted EBITDA growth in 2020 over the prior year and nearly 60% adjusted EBITDA growth in the fourth quarter over the prior year quarter [12] - Total Medicare home health admissions grew nearly 7% in 2020, while average Medicare revenue per 60-day episode grew 10% [13] - In hospice, total hospice admissions grew 32%, and average Medicare revenue per day increased 4.1% [14] Market Data and Key Metrics Changes - The average home health star rating improved to 4.3 stars, above the national average of three stars, with the percentage of agencies achieving a 5-star rating growing from 3% to 30% sequentially in the fourth quarter [15][14] - The senior living segment faced challenges with occupancy rates declining due to the pandemic, but there are expectations for recovery as vaccination efforts progress [16][18] Company Strategy and Development Direction - The company plans to focus on opportunistic acquisitions in the home health and hospice segment while navigating challenges in the senior living segment [20][21] - The strategy includes increasing the capacity of the revolving credit facility from $75 million to $150 million to support disciplined growth [19][35] - The company aims to improve the health of operating markets and strengthen the leadership pipeline for future investments [22][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in overcoming near-term challenges in the senior living segment and anticipates a return to growth in late 2021 [22][23] - The ongoing vaccine rollout is expected to bolster public confidence and unlock pent-up demand for senior living services [18] - Management affirmed 2021 annual revenue and adjusted earnings per share guidance, citing strong momentum in the home health and hospice business [22][23] Other Important Information - The company did not take the CARES Act provider relief funds, which management believes is the right course for the organization [38] - The company took care of nearly 13,000 patients and residents daily in 2020, highlighting the dedication of frontline staff during the pandemic [40] Q&A Session Summary Question: Impact of decoupling IT systems on efficiency - Management noted that freeing up manhours from IT system transitions will allow resources to focus on business growth and operational improvements [45][46] Question: Local leadership talent and pipeline - The leadership pipeline is robust, with 18 administrators in training, a third of whom are elevated internally, indicating strong internal development [50][51] Question: Quality metrics and star ratings - The average star rating improved from four stars to 4.25 stars, with the percentage of agencies achieving a 5-star rating increasing significantly [53][54] Question: Senior living occupancy projections - Management expects occupancy to stabilize and potentially increase towards the end of the year, aiming to return to pre-pandemic levels [59][61] Question: Impact of weather and business days on Q1 - Severe weather in Texas affected operations, but management remains optimistic about recovery and operational performance [69][70] Question: Length of stay in hospice - Length of stay declined meaningfully, but operators adjusted well, maintaining strong average daily census [72][73] Question: M&A activity priorities - The capital allocation strategy remains focused on home health and hospice, with less emphasis on senior living acquisitions until recovery is evident [76][77]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2020. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 _____ ...

Financial Data and Key Metrics Changes - The company reported total GAAP revenue of $98.4 million for Q3 2020, an increase of $10 million or 11.3% over the prior year quarter [32] - Adjusted revenue reached a record $96.6 million, nearly 10% higher than Q3 last year, with consolidated adjusted EBITDA of $8.6 million, a 32% increase over the same period [17][33] - Adjusted diluted earnings per share increased to $0.18, representing a 63.6% increase over the spin-adjusted third quarter 2019 results of $0.11 [33] Business Line Data and Key Metrics Changes - Home Health and Hospice operations reported total and Medicare admissions exceeding pre-pandemic levels, with record Hospice average daily census [19] - Senior Living segment experienced a decline in weighted average occupancy by approximately 370 basis points from the first quarter, standing at 76.8% in Q3, but showed a 40 basis point increase since August [21][22] Market Data and Key Metrics Changes - The company affirmed its 2020 annual revenue guidance and increased its adjusted earnings per share guidance to a range of $0.75 to $0.80, reflecting a 34% increase over initial guidance [15][37] - For 2021, the company provided revenue guidance of $430 million to $440 million and adjusted earnings per share guidance of $0.89 to $0.99, representing increases of 14.2% and 21.3% respectively over revised 2020 guidance [16][38] Company Strategy and Development Direction - The company is focused on disciplined growth through opportunistic acquisitions and has successfully completed several acquisitions and joint ventures, including four Home Health agencies and two Hospice agencies [28][30] - The management emphasized the importance of local leadership and operational resilience in navigating the challenges posed by the pandemic and the transition to the PDGM reimbursement model [20][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to continue producing strong results despite ongoing pandemic challenges, highlighting the resilience of local teams [12][16] - The company is encouraged by initial reports on vaccine efficacy and availability, which could positively impact operations in the second half of 2021 [58] Other Important Information - The company continues to benefit from approximately $28 million in advance Medicare payments and $5.3 million from the CARES Act payroll tax deferral program [35] - The management team is expanding, with Brent Guerisoli set to become President of The Pennant Group in 2021, which is expected to enhance leadership capabilities [13] Q&A Session Summary Question: Contribution of M&A to growth rates historically - Management indicated that historical trends suggest a continued pace of M&A activity in 2021, with local leaders in a strong position to capitalize on opportunities [49] Question: Occupancy trends and guidance - Management expects occupancy to continue at current levels with a slight uptick, reflecting ongoing challenges in the senior living sector [52][56] Question: Impact of vaccine distribution on operations - Management is optimistic about the potential benefits of vaccine distribution in the second half of 2021, while emphasizing the need for effective execution [58] Question: Expected operating cash flow for 2021 - Management will provide projections for operating cash flow in the investor deck [60] Question: Adjusted EPS and sequestration holiday - Management clarified that the adjusted EPS excludes the 2% add-on payment from the sequestration holiday, which is considered temporary [66] Question: Start-up operations and profitability timeline - Start-up operations are expected to reach profitability within 18 to 24 months, with adjustments made based on local market conditions [72][90] Question: Interest in joint ventures - Management noted increased interest in joint ventures, particularly with hospitals seeking solutions during the pandemic [93]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2020. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its ...

The Pennant Group, Inc. (NASDAQ:PNTG) Q2 2020 Earnings Conference Call August 12, 2020 12:00 PM ET Corporate Participants Derek Bunker - Chief Investment Officer, Executive Vice President and Secretary Danny Walker - Chairman, President and Chief Executive Officer Jennifer Freeman - Chief Financial Officer John Gochnour - Chief Operating Officer Conference Call Participants Scott Dupslaff - Stephens Frank Morgan - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by, and welcome to T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO S ...

The Pennant Group, Inc. (NASDAQ:PNTG) Q1 2020 Earnings Conference Call May 14, 2020 12:00 PM ET Company Participants Derek Bunker - Chief Investment Officer, Executive Vice President & Secretary Danny Walker - Chief Executive Officer & President Jen Freeman - Chief Financial Officer John Gochnour - Chief Operating Officer Conference Call Participants David MacDonald - SunTrust Frank Morgan - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by. And welcome to The Pennant Group First ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2020. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its Cha ...

Financial Data and Key Metrics Changes - For the full year 2019, the company reported GAAP earnings per share of $0.11 and a loss per share of $0.14 for the fourth quarter [25] - Adjusted earnings per share for the year was $0.61, with $0.16 for the quarter, primarily due to costs related to the spin-off transaction and share-based compensation [26][28] - Non-GAAP revenue for 2019 was $337.7 million, slightly below guidance, while adjusted earnings per share exceeded guidance due to lower-than-expected general and administrative costs [27][30] Business Line Data and Key Metrics Changes - Home health and hospice revenue reached nearly $207 million in 2019, a 22% increase from 2018, driven by a 24% increase in home health admissions and a 30% increase in hospice admissions [12] - Senior living segment revenue for 2019 was $132 million, a 13% increase from 2018, with total occupancy increasing by 70 basis points [16] Market Data and Key Metrics Changes - The company has been actively monitoring the spread of the coronavirus and has implemented measures to enhance screening practices and infection control [17][18] - The joint venture with Scripps Health is expected to close in the third quarter of 2020, indicating a strategic move to strengthen market presence [14] Company Strategy and Development Direction - The company aims to support local operators in navigating opportunities and challenges in their markets while focusing on organic growth and disciplined acquisition strategies [11][21] - The joint venture with Scripps Health is seen as a way to leverage the company's operating model and expand its market reach [15][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for growth in both home health and hospice segments, particularly in light of the new Patient Driven Groupings Model (PDGM) [13][49] - The company remains focused on helping the senior living team transition effectively while capitalizing on opportunities in home health and hospice [48] Other Important Information - The company acquired 11 operations across five states in 2019, including two home health agencies and five hospice agencies [20] - The company reported cash generated from operations of $9.6 million and a net debt to adjusted EBITDA ratio of 4.82 times as of December 31, 2019 [29] Q&A Session Summary Question: Can you provide more details on the cost related to leadership systems and business alignment changes in the senior living segment? - Management indicated that realignment is ongoing, particularly in Texas and California, and improvements are already being observed [40] Question: Which business segment is more at risk regarding the coronavirus? - Management noted that the senior living segment faces greater risks due to potential outbreaks, while home health and hospice operations are focused on infection control measures [42][44] Question: Where do you see the most opportunities for capital deployment this year? - Management stated that the majority of growth is expected in the home health and hospice arena, while senior housing will focus on transitioning effectively [48] Question: Can you provide details on the hospice acquisition in Missoula? - The hospice agency is relatively small, with an average daily census in the 30 to 40 range, and offers expansion opportunities in Montana [50] Question: Is the Scripps joint venture included in guidance? - Management confirmed that the joint venture is not included in current guidance as it is expected to close later in the year [51]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2019. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its Charter) ...